Araclon Biotech
Araclon Biotech, a subsidiary of Grifols, is a company specializing in the research and development of methods for the early diagnosis and preventive treatment of Alzheimer’s Disease.
We are pioneers in the development of assays based on the determination of amyloid peptides in plasma that help to detect early pathological changes of the disease, before the onset of symptoms.

Araclon Biotech
Araclon Biotech, a subsidiary of Grifols, is a company specializing in the research and development of methods for the early diagnosis and preventive treatment of Alzheimer’s Disease.
We are pioneers in the development of assays based on the determination of amyloid peptides in plasma that help to detect early pathological changes of the disease, before the onset of symptoms.

Services and R&D
ABtest-Service
The safest way to obtain reliable results from automated analysis under strictly standardized conditions and performed by highly qualified personnel.
Diagnosis
At Araclon Biotech we have developed a state-of-the-art assay that allows the simultaneous determination of total Aβ40 and Aβ42 levels.
Treatment
ABvac40 is an active vaccine against Aβ40 peptide for the preventive treatment of Alzheimer's Disease.
Development of a theraphy for de Parkinson's disease
The company has begun a diversification process, which includes an entry into the field of Parkinson's disease, another major degenerative
illness. As such, it has signed a collaboration agreement with the research group of the CSIC (Spanish National Research Council).
The therapeutic target of the project consists of the promotion of the dopaminergic differentiation of the original brain cells.
This project has already given way to the first patent, for which Aracion has the exclusive licence. Experiments are currently being carried out to test the concept on animals, in order to analyse the therapeutic potential of the molecules, and its viability to be put into clinical practice.
This Project with reference number RTC-2015-3439-1 is funded by Ministry of Economy and Competitiveness of Spain an the European Regional Development Fund (ERFD)

How can we help you?
Contact the Araclon Biotech team.